Nplate 250 MCG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCRP0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,081
Award facts
- Contract value 100% obligated
- $17,080.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,080.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nplate 250 microgram vials. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award was made on December 11, 2025, with an ultimate completion date of January 5, 2026, and performance will occur at the vendor's location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy that provides the foundational authority for the company to supply a comprehensive range of pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. The PPV-G GEN V program, awarded on November 13, 2025, with a $499,999,999 ceiling and completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor supporting recurring medical supply needs across the military healthcare system. The delivery order for Nplate vials represents the type of specialized pharmaceutical product deliverable under this broader strategic contracting vehicle.
Quick answers
Who was awarded contract SPE2DR26FCRP0?
SPE2DR26FCRP0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FCRP0 worth?
The government has obligated $17,081 on SPE2DR26FCRP0.
Is contract SPE2DR26FCRP0 an order under another contract?
Yes. SPE2DR26FCRP0 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRP0 competed?
The extent of competition for SPE2DR26FCRP0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award